/PRNewswire/ XNK Therapeutics AB ("XNK") today said the company would continue its partnership with the Karolinska Cell Therapy Center s production unit.
XNK Therapeutics continues platform development work with AdBIOPRO after Sweden's Vinnova extends investment - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ XNK Therapeutics AB ("XNK") today announced that an abstract on the long-term follow-up of the Phase I/II clinical trial ACP-001 with its.
STOCKHOLM, June 10, 2022 /PRNewswire/ XNK Therapeutics AB ("XNK") today announced that an abstract on the long-term follow-up of the Phase I/II clinical trial ACP-001 with its leading candidate